Brian Sperber is a Dermatology physician. OpenAlex indexes 13 publications with 556 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
170 S Parkside Dr
Colorado Springs, CO 809103129
Telephone
719-471-1763Provider last certified this registry record 15 Jul 2024.
Industry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202511 payments
- E.R. Squibb & Sons, L.L.C.Program year202510 payments
- Novartis Pharmaceuticals CorporationProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
22.6%Azole Antifungal10.4%Ketoconazole89%Fluconazole11%Part D<11 patientsTetracycline-class Drug3.9%Minocycline Hcl50%Doxycycline Hyclate31%Doxycycline Monohydrate19%Part D<11 patients+ 5 more classes in this area
Dermatology
21.8%Corticosteroid18.4%Triamcinolone Acetonide59%Triamcinolone acetonide33%Halobetasol Propionate4%Methylprednisolone4%Part D + Part B<11 patientsAllylamine Antifungal1%Terbinafine Hcl100%Part D≥11 patients+ 3 more classes in this area
Sensory organs
18.4%Corticosteroid18.4%Clobetasol Propionate58%Hydrocortisone27%Betamethasone acetate10%Betamethasone Dipropionate5%Part D + Part B<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting
Journal of the American Academy of Dermatology
2014 - Pemphigus2014
- Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis
Journal of the American Academy of Dermatology
2012 - A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025%.
PubMed
2012 - Pemphigus2008
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”